|
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
8 results found
| no | title | author | magazine | year | volume | issue | page(s) | type |
| 1 | ALK evaluation in the world of multiplex testing: Network Genomic Medicine (NGM): the Cologne model for implementing personalised oncology |
Heydt, C. |
|
27 | S3 |
p. iii25-iii34 |
article |
|
| 2 | Crizotinib: from discovery to accelerated development to front-line treatment |
Blackhall, F. |
|
27 | S3 |
p. iii35-iii41 |
article |
|
| 3 | Crizotinib resistance: implications for therapeutic strategies |
Dagogo-Jack, I. |
|
27 | S3 |
p. iii42-iii50 |
article |
|
| 4 | Editorial board |
|
27 | S3 |
p. ii-iii |
article |
||
| 5 | Precision medicine in NSCLC and pathology: how does ALK fit in the pathway? |
Kerr, K.M. |
|
27 | S3 |
p. iii16-iii24 |
article |
|
| 6 | Table of Contents |
|
27 | S3 |
p. iv |
article |
||
| 7 | The continuum of care for ALK-positive NSCLC: from diagnosis to new treatment options – an overview |
Solomon, B. |
|
27 | S3 |
p. iii1-iii3 |
article |
|
| 8 | The role of the ALK receptor in cancer biology |
Hallberg, B. |
|
27 | S3 |
p. iii4-iii15 |
article |
8 results found